OneMedNet Corporation
ONMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -37% | -11.4% | 5.6% | – |
| Cost of Goods Sold | $1 | $1 | $2 | $1 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -43.7% | -12.6% | -31.2% | -10.4% |
| R&D Expenses | $1 | $2 | $2 | $1 |
| G&A Expenses | $7 | $4 | $13 | $1 |
| SG&A Expenses | $8 | $5 | $14 | $2 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | -$8 | $0 |
| Operating Expenses | $9 | $7 | $7 | $3 |
| Operating Income | -$10 | -$7 | -$8 | -$3 |
| % Margin | -1,493.8% | -671.2% | -669.1% | -248.3% |
| Other Income/Exp. Net | -$1 | -$27 | -$23 | -$0 |
| Pre-Tax Income | -$10 | -$34 | -$30 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$34 | -$30 | -$3 |
| % Margin | -1,575.3% | -3,308.5% | -2,641% | -269.4% |
| EPS | -0.36 | -4.77 | -2.51 | -0.2 |
| % Growth | 92.5% | -90% | -1,155% | – |
| EPS Diluted | -0.36 | -4.77 | -2.51 | -0.2 |
| Weighted Avg Shares Out | 28 | 7 | 12 | 15 |
| Weighted Avg Shares Out Dil | 28 | 7 | 12 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$34 | -$30 | -$3 |
| % Margin | -1,543.2% | -3,302.9% | -2,637.4% | -250.1% |